The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 10, 2022
Filed:
Jun. 12, 2018
Applicant:
Igf Oncology, Llc, Pine Springs, MN (US);
Inventors:
Hugh McTavish, Pine Springs, MN (US);
Arkadiusz Z. Dudek, Vadnais Heights, MN (US);
Assignee:
IGF Oncology, LLC, Pine Springs, MN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/64 (2017.01); A61P 35/02 (2006.01); A61K 38/30 (2006.01); A61P 7/00 (2006.01); A61K 31/7068 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6425 (2017.08); A61K 31/7068 (2013.01); A61K 38/30 (2013.01); A61K 47/64 (2017.08); A61P 7/00 (2018.01); A61P 35/02 (2018.01); A61K 31/519 (2013.01);
Abstract
Provided are methods of treating myelodysplastic syndrome (MDS), oligoblastic acute myelogenous leukemia (O-AML), or chronic myelomonocytic leukemia (CMML) using 765IGF-MTX and other IGF-receptor-targeted agents, and formulations for delivering 765IGF-MTX and other IGF-receptor-targeted agents to patients. Also provided are pharmaceutical compositions for use in treating MDS, O-AML, and CMML.